Dissertation Sep 18, 2015: Viktoria Johansson "Cerebrospinal fluid biomarkers in twins with schizophrenia and bipolar disorder"

Published 2015-09-14 16:35. Updated 2015-12-07 16:33Denna sida på svenska

On September 18, Viktoria Johansson will defend her thesis "Cerebrospinal fluid biomarkers in twins with schizophrenia and bipolar disorder". Her opponent is professor Sophia Frangou from Mount Sinai Hospital in New York and her supervisors are professorns Christina Hultman and Mikael Landén and professor emeritus Lennart Wetterberg.

The aim of Viktoria's thesis work was to examine potential biomarkers for schizophrenia and bipolar disease by analysing cerebrospinal fluid, surrounding the brain and spine. Previously identified cerebrospinal fluid (CSF) biomarkers were studied in 37 twins with schizophrenia or bipolar disorder to determine their genetic and environmental properties. Further, comorbidities and sibling risks were investigated in patients with schizophrenia (n=22,781), bipolar disorder (n=30,761) and depression (n=172,479) in relation to multiple sclerosis (MS) (n=16,467) in a nationwide cohort.

Time and location: 9:00 am, Sep 18 2015 in the lecture hall Petrén, Nobels väg 12B, Solna Campus.

EpidemiologyPsychiatric disordersTwin research